IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Quarterly activities report and Appendix 4C, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 321 Posts.
    lightbulb Created with Sketch. 739
    Did you read the quarterly?

    $321k plus they completed the raise of $735k in January post quarter end.

    R&D rebate due any tick which they said previously they expected circa $300k plus this and quarter and next are the two biggest revenue quarters.

    This quarter last year was around $400k in revenue and given organic growth I suspect the number to be much highe with the additional strings to the bow, 1300 partnership, retail, boil and bite etc. 

    Add all that up cash plus placement post quarter plus r & d plus even last years rev with no growth you end up with over $1.7 million.

    Add in the cannabis upside and I think all is on track.

    Ted
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.